Patent · US Active

Oral composition containing difructose anhydride

US8530446B2 · kind B2 · utility

0Cited by
1References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 25, 2005
Grant dateSep 10, 2013
Priority date
Expiry dateMar 5, 2030

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An oral composition for increasing equol production by inner-intestinal bacteria, wherein such composition contains difructose anhydride as an active ingredient to activate the equol production function of inner-intestinal bacteria.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.